Skip to content
Luvida Health

Important: Compounded medications discussed on this page are prepared by Rush Pharmacy or Epiq Scripts, state-licensed compounding pharmacies, for an individual patient pursuant to a valid prescription and are not FDA-approved drug products. Submitting an intake or payment through Luvida Health does not guarantee a prescription. An independent licensed provider from LocumTele will review your information and determine whether treatment is clinically appropriate for you. An asynchronous consult or a video consult may be required. Individual experiences and results vary and are never guaranteed.

Our Focus

Two therapies, evaluated properly.

We offer compounded semaglutide and compounded tirzepatide: nothing else. A narrow focus means your clinician evaluates you against a well-understood set of care options. Eligibility is decided by an independent licensed provider from LocumTele, and completing an intake does not guarantee a prescription.

Treatment Overview

FeatureCompounded SemaglutideCompounded Tirzepatide
Drug ClassGLP-1 Receptor AgonistDual GIP and GLP-1 Receptor Therapy
Care ContextMedically supervised weight-management care for eligible adultsMedically supervised weight-management care for eligible adults
Clinical EvaluationIndependent licensed clinician review via asynchronous or video consultIndependent licensed clinician review via asynchronous or video consult
Regulatory StatusCompounded drug product: Not FDA-approved; not reviewed by the FDA for safety, effectiveness, or qualityCompounded drug product: Not FDA-approved; not reviewed by the FDA for safety, effectiveness, or quality
Prescription RequirementPrescription required; an intake or payment does not guarantee a prescriptionPrescription required; an intake or payment does not guarantee a prescription
Dispensing PharmaciesState-licensed U.S. compounding pharmacies: Rush Pharmacy or Epiq ScriptsState-licensed U.S. compounding pharmacies: Rush Pharmacy or Epiq Scripts
Fulfillment FormatPrepared for an individual patient pursuant to a valid prescription; shipped discreetlyPrepared for an individual patient pursuant to a valid prescription; shipped discreetly
Illustrative vial of compounded semaglutide. Actual medication and packaging may differ.

Compounded Semaglutide

  • Therapeutic Class: GLP-1 Receptor Agonist
  • Requirement: Prescription required
  • Clinical Overview: Semaglutide belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist class, used in medically supervised weight-management care for adults who meet specific clinical criteria evaluated by an independent clinician. Through Luvida Health, an independent licensed provider may prescribe a compounded formulation when clinically appropriate.
  • Compounding & Regulatory Notice: When compounded, it is prepared by Rush Pharmacy or Epiq Scripts for an individual patient and is not an FDA-approved drug product. The FDA has not reviewed compounded semaglutide for safety, effectiveness, or quality. Compounded semaglutide is not manufactured by or affiliated with Novo Nordisk A/S.
Illustrative vial of compounded tirzepatide. Actual medication and packaging may differ.

Compounded Tirzepatide

  • Therapeutic Class: Dual GIP and GLP-1 Receptor Therapy
  • Requirement: Prescription required
  • Clinical Overview: Tirzepatide belongs to the dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor therapy class, used in medically supervised weight-management care for adults who meet specific clinical criteria evaluated by an independent clinician. Through Luvida Health, an independent licensed provider may prescribe a compounded formulation when clinically appropriate.
  • Compounding & Regulatory Notice: When compounded, it is prepared by Rush Pharmacy or Epiq Scripts for an individual patient and is not an FDA-approved drug product. The FDA has not reviewed compounded tirzepatide for safety, effectiveness, or quality. Compounded tirzepatide is not manufactured by or affiliated with Eli Lilly and Company.

Serious Safety Information & Contraindications

Compounded GLP-1 therapies are prescription medications that carry clinical risks. Discuss your complete health history with your provider before starting.

  • Boxed Warning for Thyroid C-Cell Tumors: In rodent studies, GLP-1 receptor therapies have caused thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), a rare type of thyroid cancer. It is unknown whether these medications cause thyroid C-cell tumors, including MTC, in humans.
  • Strict Contraindications: Do not use GLP-1 medications if you or any member of your family has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), a rare genetic syndrome that causes tumors in hormone-producing glands.
  • Allergies: Do not use these medications if you have had a serious allergic reaction to semaglutide, tirzepatide, or any inactive ingredients.
  • Pregnancy & Nursing: Do not use GLP-1 medications if you are pregnant, planning to become pregnant, or breastfeeding. Consult your healthcare provider regarding pregnancy and medication use.
  • Other Health Conditions: Tell your clinician about all medical conditions, including any history of pancreatitis, gallbladder issues, kidney problems, severe stomach conditions, or diabetic eye problems.
  • Side Effects: Common side effects include nausea, diarrhea, vomiting, constipation, stomach discomfort, and fatigue. Some side effects can be serious.

Find out whether treatment is clinically appropriate for you.

Start your secure intake and an independent licensed clinician from LocumTele will review your medical history.

Prescription required. Adults 18+ only. Available in 50 U.S. states. Compounded medications are not FDA-approved. Individual results vary and are never guaranteed. Not for emergencies: Call 911, or call or text 988.